CIK: 0001821219 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 10, 2020
Total Value ($000): $67,776 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JPM | JPMORGAN CHASE | 245,000 | $23,586 | 34.8% | $81.74 | +4.5% | COMMON EQUITY | 46625H100 |
| PGR | PROGRESSIVE CORP | 45,000 | $4,260 | 6.3% | $66.35 | +15.3% | COMMON EQUITY | 743315103 |
| WAL | WESTERN ALLIANCE BANCORP | 120,000 | $3,794 | 5.6% | $30.98 | +2.4% | COMMON EQUITY | 957638109 |
| KKR | KKR | 100,000 | $3,434 | 5.1% | $25.46 | +30.8% | COMMON EQUITY | 48251W104 |
| ACN | ACCENTURE PLC CL A | 15,000 | $3,390 | 5.0% | $174.62 | +21.6% | COMMON EQUITY | G1151C101 |
| BRK/A | BERKSHIRE HATHAWAY INC CL A | 10 | $3,200 | 4.7% | $274034.30 | +12.0% | COMMON EQUITY | 084670108 |
| — | OXFORD IMMUNOTEC GLOBAL PLC | 272,281 | $3,186 | 4.7% | $13.00 | — | COMMON EQUITY | G6855A103 |
| AON | AON PLC CLASS A | 15,000 | $3,095 | 4.6% | $178.56 | +7.4% | COMMON EQUITY | G0403H108 |
| GS | GOLDMAN SACHS GROUP INC | 15,000 | $3,014 | 4.4% | $164.18 | +9.0% | COMMON EQUITY | 38141G104 |
| OZK | BANK OZK | 125,000 | $2,665 | 3.9% | $17.43 | +10.1% | COMMON EQUITY | 06417N103 |
| AXP | AMERICAN EXPRESS CO | 25,000 | $2,506 | 3.7% | $85.61 | +7.3% | COMMON EQUITY | 025816109 |
| NTRS | NORTHERN TRUST CORP | 30,000 | $2,339 | 3.5% | $66.60 | +2.1% | COMMON EQUITY | 665859104 |
| C | CITIGROUP INC | 50,000 | $2,156 | 3.2% | $38.68 | +6.0% | COMMON EQUITY | 172967424 |
| — | CADENCE BANCORP | 250,000 | $2,148 | 3.2% | $8.86 | — | COMMON EQUITY | 12739A100 |
| SCHW | SCHWAB (CHARLES) CORP | 50,000 | $1,812 | 2.7% | $33.18 | -2.3% | COMMON EQUITY | 808513105 |
| WFC | WELLS FARGO | 70,000 | $1,646 | 2.4% | $23.98 | -9.0% | COMMON EQUITY | 949746101 |
| — | AMRYT PHARMA LTD - SPNR ADR | 125,000 | $1,545 | 2.3% | $12.36 | — | COMMON EQUITY | 03217L106 |